NCT03861377View on ClinicalTrials.gov

Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses.

PHASE4CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

February 2, 2022

Study Completion Date

February 2, 2022

Conditions
Hemodynamic InstabilityAnesthesia, GeneralAnesthesia, Intravenous
Interventions
DRUG

Remifentanil R2

0,7 microg/kg

DRUG

Remifentanil R4

1,1 microg/kg

DRUG

Remifentanil R8

1,7 microg/kg

Trial Locations (1)

5504

Kirurgisk Klinikk Anestesi, Haugesund

All Listed Sponsors
lead

Helse Fonna

OTHER

NCT03861377 - Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses. | Biotech Hunter | Biotech Hunter